Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy ...
Gen Z Could Help Uplift the High-Street in 2025 Gen Z are the most optimistic age group of the nation, with almost a quarter (24%) of Gen Zers spending more money now than they did 12 months ago, and ...
Penetration testing, i.e. the self-assessment of a company's IT infrastructure to test its cyber resilience, is too often neglected in the business world, warns Keith Poyser, Vice President for EMEA ...